Light Mode
$15.19 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.19, $0.80 below the day’s high of $15.99
-6.71 (-30.64%) / 6M
Momentum, market sentiment, and recent alerts
ATTO reads not so good: the 12-month move is -30.6%.
No alerts for ATTO in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.